Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

43.95p
   
  • Change Today:
      1.55p
  • 52 Week High: 48.40
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 1,448,322
  • Market Cap: £237.58m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.
Registrars: Capita Registrars

Key Personnel

CEO: Nick Sedgwick
CFO: Andrew Franklin
Chairman: Camillo Pane
Chief Operating Officer: Jeyan Heper
Independent Non-Executive Director: Martin Sutherland
Independent Non-Executive Director: Kristof Neirynck
Senior Independent Director: Richard Jones
Non-Executive Dir: Eva-Lotta Sjöstedt, Richard McKenzie

Contact Details

Address: Avonbridge House, Bath Road, Chippenham, Wiltshire, United Kingdom, SN15 2BB
Phone: +44 (0)1249 466966
Fax: +44 (0)1249 466977
Website: http://www.alliancepharma.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0031030819

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 43.95p
Change Today 1.55p
% Change 3.66 %
52 Week High 48.40
52 Week Low 29.35
Volume 1,448,322
Shares Issued 540.57m
Market Cap £237.58m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.50% above the market average11.50% above the market average11.50% above the market average11.50% above the market average11.50% above the market average
91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average
Price Trend
20.79% below the market average20.79% below the market average20.79% below the market average20.79% below the market average20.79% below the market average
18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average
Income Not Available
Growth
42.24% below the market average42.24% below the market average42.24% below the market average42.24% below the market average42.24% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 13-Sep-2024

Time Volume / Share Price
16:08 6,433 @ 43.95p
16:08 383 @ 43.95p
16:08 2,200 @ 43.95p
16:08 1,132 @ 44.23p
16:01 500 @ 44.00p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page